95-0128: LORAZEPAM INJECTION.
The LORAZEPAM INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 1.000 MILLILITERS, controlled_substance_classification: SCHEDULE IV. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-411-2724, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | VIAL |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 1.000 MILLILITERS |
| controlled_substance_classification | SCHEDULE IV |
| active_medicament_medicinal_strength | 2.000 MILLIGRAMS LORAZEPAM PER MILLILITER |
| part_name_assigned_by_controlling_agency | LORAZEPAM INJECTION 2MG/ML 1ML VIAL 25S PG |
| NSN | 6505-01-411-2724 |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LORAZEPAM INJECTION 2MG/ML 1ML VIAL 25S PG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 MILLIGRAMS LORAZEPAM PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
No substitute or cross-reference records for this part.